NEW Webinar! Emerging Therapeutic Frontiers in Pediatric IBD
Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics February 25, 2026 8PM ET As therapeutic...
Job Interview Coaching Workshop for 2nd Year Fellows 2026
The NASPGHAN Med Ed SIG is proud to again offer a program for personalized job interview coaching for current 2nd Year...
NASPGHAN Reaccredited by ACCME for the Next Four Years
NASPGHAN is proud to announce that we have been reaccredited by the Accreditation Council for Continuing Medical Education (ACCME) for...
NASPGHAN Joins Partner Societies in Urging CDC to Maintain Universal Hepatitis B Birth Dose
NASPGHAN has joined the American Association for the Study of Liver Diseases (AASLD), the American College of Gastroenterology (ACG), the...
The universal hepatitis B birth dose must be protected.
NASPGHAN Urges ACIP to Maintain the Universal Hepatitis B Birth-Dose Recommendation The universal hepatitis B birth-dose vaccination remains a critical,...
A RECORD BREAKING YEAR
We loved seeing everyone in Chicago for the 2025 Annual Meeting for a truly a record breaking year. More than...
